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Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen in
humans and a frequent cause of asymptomatic, persistent infections leading to serious
complications, particularly in young women. Chlamydia displays a unique obligate
intracellular lifestyle involving the infectious elementary body and the replicative reticulate
body. In the presence of stressors such as gamma-interferon (IFNγ) or beta-lactam
antibiotics, C. trachomatis undergoes an interruption in its replication cycle and enters a
viable but non-cultivable state. Upon removal of the stressors, surviving C. trachomatis
resume cell division and developmental transitions. In this report, we describe a genetic
screen to identify C. trachomatis mutants with defects in recovery from IFNγ- and/or
penicillin-induced stress and characterized a chemically derived C. trachomatis mutant
strain that exhibited a significant decrease in recovery from IFNγ- but not penicillin-
induced stress. Through lateral gene transfer and targeted insertional gene inactivation
we identified ptr, encoding a predicted protease, as a gene required for recovery
from IFNγ-induced stress. A C. trachomatis LGV-L2 ptr-null strain displayed reduced
generation of infectious progeny and impaired genome replication upon removal of
IFNγ. This defect was restored by introducing a wild type copy of ptr on a plasmid,
indicating that Ptr is required for a rapid growth upon removal of IFNγ. Ptr was expressed
throughout the developmental cycle and localized to the inclusion lumen. Overall, our
findings indicate that the putative secreted protease Ptr is required for C. trachomatis to
specifically recover from IFNγ- but not penicillin-induced stress.
Keywords: Chlamydia trachomatis, persistence, penicillin, PTR, IFNγ-induced stress, IFNγ
INTRODUCTION
Chlamydia trachomatis is an obligate intracellular bacterium causing a significant burden on human
health due to widespread oculo-genital infections. C. trachomatis is the leading cause of bacterial
sexually transmitted infections (Newman et al., 2015). It is estimated that >70% of C. trachomatis
endocervical infections are asymptomatic and can persist for prolonged periods of time in the
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absence of treatment (Stamm, 1999). This contributes to the
perpetuity of the transmission cycle, and to the establishment
of chronic inflammation and scarring that ultimately lead to
complications such as pelvic inflammatory disease, ectopic
pregnancy and infertility (Stamm, 1999; Dean et al., 2000;
Joyner et al., 2002; Geisler et al., 2008; Haggerty et al., 2010).
C. trachomatis is also the etiologic agent of trachoma, a
long-term ocular infection and the most frequent cause of
infectious blindness (World Health Organization [WHO], 2015;
Zambrano et al., 2016). Other infections caused by C. trachomatis
include ophthalmia neonatorum and pneumonia in newborns,
inclusion conjunctivitis and less frequently lymphogranuloma
venereum (Stenberg and Mardh, 1991; Darville, 2005; White,
2009; Hammerschlag, 2011).
Chlamydia trachomatis alternates between developmental
forms showing distinct morphological and functional features
(reviewed in Hackstadt, 1999; Abdelrahman and Belland, 2005;
Tan, 2012; Elwell et al., 2016). The elementary body (EB)
is infectious, environmentally stable, smaller, condensed and
non-replicative. The reticulate body (RB) is non-infectious,
labile in the extracellular milieu, larger and replicative. The
infectious cycle begins when EBs attach to epithelial cells and
are internalized into a membrane-bound vacuole, termed an
inclusion, which serves as a replicative niche for this bacterium.
Soon after internalization, EBs transition into RBs, which actively
replicate. At the mid-cycle of infection, RBs start differentiating
back into EBs in an asynchronous manner, such that at late
stages post-infection the inclusion contains numerous EBs. At
the end of the cycle, the inclusion occupies most of the host
cell cytoplasm and the bacteria are released either by cell
lysis or extrusion of intact inclusions (Hybiske and Stephens,
2007). Once in the extracellular environment, EBs are able to
infect other cells and continue their infectious cycle. When
C. trachomatis is stressed during infection, like upon exposure
to certain antibiotics, cytokines or nutrient deprivation, these
bacteria are able to enter into a viable but non-cultivable
state, commonly referred to as “Chlamydia persistence” or
“Chlamydia stress response.” Under this state, Chlamydia halts
bacterial division and infectious particle generation and usually
displays morphologically aberrant and enlarged RBs (aRBs),
which are able to rapidly reactivate and resume propagation
upon withdrawal of the stressing conditions (reviewed in Wyrick,
2010; Schoborg, 2011; Tan, 2012). The ability to reactivate
from a variety of stresses allows Chlamydia to ensure long-
lasting survival while facing unfavorable growth conditions
in vitro. Importantly, morphological and clinical evidence suggest
that this type of response also occurs in vivo. For instance,
C. muridarum aRBs have been observed in murine endocervical
cells using a female genital tract model of infection (Rank et al.,
2011; Phillips Campbell et al., 2012), while C. trachomatis aRBs
were reported in human endocervix (Lewis et al., 2014). In
addition, post-gonococcal urethritis reported in C. trachomatis
co-infected patients treated with penicillin, a known inducer of
Chlamydia persistence in vitro and in vivo, may be considered
clinical evidence of reactivation upon completion of the
antibiotic regime (Wyrick, 2010; Phillips Campbell et al., 2012;
Augenbraun, 2015). A variety of stressors have been described to
elicit a reversible interruption in Chlamydia growth in vitro, such
us penicillin, IFNγ, deprivation of amino acids, iron, or glucose,
as well as exposure to cigarette smoke components, adenosine,
co-infection with Porcine Epidemic Diarrhea or Herpes Simplex
viruses, infection with a phage and heat-shock (Beatty et al.,
1994b; Hsia et al., 2000; Wiedeman et al., 2005; Huston et al.,
2008; Pettengill et al., 2009; Vanover et al., 2010; Schoborg, 2011;
Prusty et al., 2012; Schoborg and Borel, 2014). Among these, the
most extensively studied are IFNγ and penicillin. IFNγ, produced
by T-lymphocytes and NK cells, is an important cytokine
with critical roles in the immune response against intracellular
pathogens (McClarty et al., 2007; Billiau and Matthys, 2009;
Aiyar et al., 2014). Different studies confirmed that IFNγ is
able to restrict C. trachomatis growth in cell culture models
of infection (Beatty et al., 1993; Morrison, 2000). In human
epithelial cells, this inhibitory effect is mainly due to IFNγ-
mediated activation of indoleamine-2,3-dioxygenase (IDO), an
enzyme that catabolizes tryptophan into kynurenine, leading to
nutritional stress due to Chlamydia being tryptophan auxotrophs
(Rapoza et al., 1991; Beatty et al., 1993, 1994a). This is in
line with observations that IFNγ-responsive IDO-deficient cells
or addition of exogenous tryptophan to the culture media,
both rescue IFNγ-induced growth restriction in C. trachomatis
(Beatty et al., 1994a). Interestingly, as opposed to trachoma-
associated serovars, C. trachomatis genital serovars encode a
tryptophan synthase (TrpB) that can synthesize tryptophan from
indole (Fehlner-Gardiner et al., 2002). This is in agreement with
reports showing that loss-of-function trpB mutations are found
in ocular but not genital serovars, and are consistent with the
observation that addition of exogenous indole allows genital
but not trachoma serovars to exit from IFNγ-induced stress
(Caldwell et al., 2003; Aiyar et al., 2014). Moreover, a knock-out
of trpB is sufficient to block recovery after addition of indole
in C. trachomatis serovar D (Kari et al., 2011). Given that the
genital tract microbiota contains indole-producing bacteria, it
has been proposed that C. trachomatis genital serovars may
rely on their tryptophan synthase to evade the antimicrobial
effects triggered by IFNγ during in vivo infections (Caldwell
et al., 2003). In human cells, it has been reported that IFNγ
also mediates IDO-independent anti-Chlamydia effects via the
induction of a family of cell-autonomous p65 guanylate binding
proteins (GBPs) (Tietzel et al., 2009; Al-Zeer et al., 2013),
although this growth restriction is not always observed (Johnston
et al., 2016). Penicillins are beta-lactam antibiotics that inactivate
penicillin binding proteins (PBPs), leading to inhibition of
peptidoglycan cross-linking, which is required for bacterial cell
wall synthesis (reviewed in Sauvage et al., 2008). Addition of
penicillin to the culture media was one of the first stimuli
shown to induce Chlamydia persistence in vitro (Beatty et al.,
1994b and references therein). Penicillin fails to block EB to RB
transition but prevents RB division, rendering inclusions that
contain a few aRBs and halting differentiation into EBs until
removal of the antibiotic (Galasso and Manire, 1961; Matsumoto
and Manire, 1970; Skilton et al., 2009). Even though it is not
clear how penicillins induce a stress response in Chlamydia,
the mechanism is likely linked to the disruption of cell wall
synthesis. The observation that amoxicillin, a widely prescribed
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antibiotic belonging to the penicillin group, induces Chlamydia
persistence in a murine model of infection (Phillips Campbell
et al., 2012), highlights the potential relevance of penicillin-
induced persistence in vivo.
Several studies have shown that the transcriptional responses
triggered in Chlamydia are not the same across different stress
models, suggesting that specific Chlamydia genes participate in
regulating the response to different stressful stimuli (Mathews
et al., 2001; Belland et al., 2003; Gerard et al., 2004; Goellner
et al., 2006; Ouellette et al., 2006; Maurer et al., 2007;
Brinkworth et al., 2018). Due to Chlamydia being refractory
to genetic manipulation until recently (reviewed in McClure
et al., 2017; Brothwell et al., 2018; Rahnama and Fields,
2018), the genes involved in such response remain largely
unknown. Notably, Muramatsu et al. (2016) carried out a
genetic screen aimed at identifying C. trachomatis mutants
defective for recovery from IFNγ-induced persistence. Using
a GFP-expressing C. trachomatis lymphogranuloma venereum
(LGV) serovar L2 library of mutants, these authors identified
six strains displaying impaired recovery upon removal of IFNγ
and mapped the mutations responsible for the phenotype to
non-synonymous mutations in TrpB (beta subunit of tryptophan
synthase), CTL0225 (putative integral membrane protein) and
CTL0694 (putative oxidoreductase).
In this study, we carried out a screen to identify C. trachomatis
genes important for recovery from IFNγ- and/or penicillin-
induced stress. We found that ptr, encoding a poorly
characterized secreted protease, is required for rapid recovery
from IFNγ- but not penicillin-induced stress.
MATERIALS AND METHODS
Cell Culture, Infection and
C. trachomatis Strains
HeLa (CCL-2, ATCC) and Vero cells (CCL-81, ATCC)
were cultured in high glucose Dulbecco’s modified Eagle’s
medium (Gibco) supplemented with 10% FBS (Natocor) without
antibiotics in 5% CO2 at 37◦C in a humidified atmosphere.
Cells were routinely checked for Mycoplasma contamination
using PCR, as described previously (van Kuppeveld et al., 1992).
Infections were done by adding a previously titered suspension
of purified EBs at the specified multiplicity of infection (MOI) in
culture media to cell monolayers, followed by centrifugation at
2,500 × g, 10◦C, 30 min. Then infected cells were transferred to
a tissue-culture incubator for the indicated hours post infection
(hpi). EB purifications were carried out as described in Saka
et al. (2011). EB stocks were titered by assessing the number
of Inclusion Forming Units (IFUs) per microliter as described
in Nguyen and Valdivia (2012), with minor modifications.
Briefly, serial dilutions of EBs were added to Vero or HeLa
cell monolayers seeded onto 96-well plates. At 24–30 hpi, cells
were fixed with ice-cold methanol (15 min) and stained with
rabbit anti-Slc1 (CT043) antibodies (Saka et al., 2011). Inclusions
were visualized and counted using a Leica DMI8 epifluorescence
microscope (Leica Microsystems).C. trachomatis LGV-L2 434/Bu
ATCC VR-902B (L2 wt), its rifampin-resistant variant RifR
(RifR wt) (Nguyen and Valdivia, 2012) and derivatives used in
this study were propagated in Vero or HeLa cells and stored
in sucrose phosphate glutamate buffer (SPG) at −80◦C. The
mutant collection used in this study was obtained using an
ethyl methyl sulfonate (EMS)-based mutagenesis method as
previously described (Kari et al., 2011; Nguyen and Valdivia,
2012). A detailed description of the collection can be found
in a previous publication (Kokes et al., 2015). M275 and the
other mutants from the collection were sequenced as specified
earlier (Snavely et al., 2014). C. trachomatis recombinants were
generated by lateral gene transfer and genotyped by TILLING
(Till et al., 2006; Kari et al., 2011; Nguyen and Valdivia, 2012).
C. trachomatis LGV-L2 ptr::GII (L2 ptr::GII) was generated by
insertion of a spectinomycin resistance cassette (aadA) in ptr (see
sections below). L2 ptr::GII was complemented with a derivative
of pBOMB4R-MCI (GenBank accession no. KF790909) (Bauler
and Hackstadt, 2014) constitutively expressing Ptr-FLAG (L2
ptr::GII PTR-F). C. trachomatis LGV-L2 control strain was also
transformed with a derivative of pBOMB4R-MCI expressing
Ptr-FLAG (L2 PTR-F). C. trachomatis LGV-L2 expressing
mCherry was obtained by transformation with the plasmid
p2TK2-SW2-IncDPromoter-mCherry (Agaisse and Derre, 2013).
C. trachomatis LGV-L2 was transformed with pMC71 (pCT143-
2HA) (da Cunha et al., 2017) to allow expression of CT143
fused to an HA epitope tag. Vector construction and Chlamydia
transformation are detailed below. C. trachomatis L2 wt and its
RifR derivative were used as control strains, as indicated.
Forward Genetic Screen for Mutants
Exhibiting Impaired Recovery Upon IFNγ
or Penicillin-Induced Stress
Four identical arrays of the mutant strains were prepared to
determine the (i) input (30 hpi), (ii) generation of IFUs in
the untreated (control) condition (30 hpi), (iii) generation of
IFUs post-IFNγ-induced stress (24 h recovery, 48 hpi) and (iv)
generation of IFUs post penicillin-induced stress (24 h recovery,
48 hpi). For IFNγ-induced stress and recovery, HeLa cells were
seeded in 96-well plates and pre-treated with IFNγ (15 ng/mL,
Peprotech) for 24 h, after which cells were washed once with
phosphate buffer saline (PBS) and infected with 5 µL of crude
cell lysates derived from each mutant in the library in a final
volume of 100 µL of DMEM, 10% FBS, IFNγ (15 ng/mL)
per well. At the time of infection, cell confluency was ∼80%.
At 24 hpi, cells were washed once with PBS, replenished with
DMEM, 10% FBS, tryptophan (100 mg/L, Sigma-Aldrich) and
let to recover for additional 24 h. At 48 hpi (24 h after IFNγ
removal and tryptophan supplementation), cells were lysed with
water to release infectious particles and the appropriate volume
of SPG 5x was added to obtain a final resuspension of the
lysates in SPG 1x. Later, these lysates were used to perform IFU
assays and determine infectious progeny generation normalized
per input. For penicillin-induced stress and recovery, a similar
procedure was carried out except that penicillin G (1 IU/mL,
Sigma–Aldrich) was added to HeLa cells at the time of infection
and at 24 hpi cells were washed once with PBS, replenished
with DMEM, 10% FBS and let to recover for additional 24 h in
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order to evaluate the generation of IFUs at 48 hpi (24 h after
penicillin removal). As control, multiple replicates of the parental
C. trachomatis LGV-L2 control strain were included in the arrays
at various MOIs (0.5, 2, 4) and used to determine the cut-off
values for impaired recovery (set as 10 and 20% of IFU/Input
of the parental strain for IFNγ and penicillin, respectively). All
mutants exhibiting a ≥ 3 fold reduction in IFU/Input compared
to the LGV-L2 control strain in the untreated condition were
considered to have a growth defect and excluded from the
analysis, since these mutants normally generate reduced IFUs
even in the absence of stress induction. Inclusions were stained
with rabbit anti-Slc1 antibodies followed by Alexa Fluor 594
anti-Rabbit IgG (Life Technologies) and Hoechst 33258 (Life
Technologies) was used to stain host cell and Chlamydia DNA.
Imaging and counting was carried out with Cellomics HTC
Arrayscan (Thermo Fisher Scientific) and images analyzed with
Cellomics vHCS: View Software v1.6 (Thermo Fisher Scientific)
to calculate the IFU values.
IFNγ and Penicillin Stress Induction and
Reactivation Assays
For IFNγ-induced stress and recovery assays, cells were seeded
and pre-treated with IFNγ (15 ng/mL) for 24 h. Then, media
was removed, and cells were infected with an MOI of 0.8 for
each strain in presence of IFNγ (15 ng/mL). After 24 h media
was removed, cells were rinsed once with PBS, fresh media
supplemented with an excess of tryptophan (DMEM, 10% FBS,
tryptophan 100 mg/L) was added and cells were allowed to
recover in the incubator for the specified times. At 48, 56,
and 72 hpi (corresponding to 24, 32, and 48 h of recovery,
respectively) media was removed, cells were lysed with water
and resuspended in SPG 1x. These lysates were used to perform
IFU assays and determine the progeny generation. Briefly, HeLa
cells were infected with serial dilutions of these lysates for 30 h
and then fixed with methanol. For penicillin-induced stress
and recovery assays, HeLa cells were infected with an MOI of
0.8 for each strain and penicillin (1 IU/mL) was added at the
time of infection. After 24 h, cells were rinsed once with PBS,
penicillin-free media (DMEM 10% FBS) was added and cells were
allowed to recover in the incubator for various times. At 48,
56, and 72 hpi (corresponding to 24, 32, and 48 h of recovery,
respectively) media was removed, cells were lysed with water to
release infectious particles and the appropriate volume of SPG
5x was added to obtain a final resuspension of the lysates in
SPG 1x. These lysates were used to enumerate the number of
IFUs and determine infectious progeny generation as described
above. Inclusions were identified with an anti-Slc1 antibody
and Alexa Fluor 488 anti-rabbit secondary antibody. Inclusions
were imaged with a 20x objective in a Leica DMI8 microscope.
The number of inclusions was assessed using an ImageJ macro
developed in our laboratory. Non-recovery control was always
included, these wells were treated for 48, 56, and 72 hpi with
penicillin or IFNγ. At all times, progeny was normalized to the
input. To calculate the input, HeLa cells infected with an MOI of
0.8 for each strain were methanol-fixed at 30 hpi and inclusions
were stained and quantified as described above.
Chlamydia Transformation
Chlamydia transformations were performed as described
previously (Wang et al., 2011) with minor modifications. Briefly,
108 infectious forming units were mixed with 10–20 µg of the
plasmid of interest in CaCl2 buffer (50 mM, pH = 7.4) and
incubated for 30 min at room temperature. Then, the mix was
added to a confluent monolayer of Vero cells seeded in all wells
of a 6-well plate. Twelve hours post infection spectinomycin
200 µg/mL (Sigma-Aldrich) or penicillin 1 IU/mL were added,
depending on the selectable marker used. At 40–48 hpi crude
lysates of infected cells were prepared by osmotic lysis (passage
0/P0) and immediately used to infect a 6-well plate seeded
with fresh Vero cells. At 40–48 hpi the harvesting step was
repeated, and the crude lysates (P1) used to infect half of a
12-well plate seeded with Vero cells. Passages were repeated
every 40–48 h until the appearance of transformants (P2-Px),
which normally occurred before P6. Antibiotic was added in
all passages for selection. After that, in order to isolate clonal
populations transformants were plaque purified as previously
described (Matsumoto et al., 1998; Nguyen and Valdivia, 2012)
with minor modifications. Briefly, confluent monolayers of Vero
cells seeded onto a 6-well plate were infected with serial dilutions
of the transformants. At 2 hpi post infection cells were overlayed
with DMEM/agarose [0.5% LE agarose (INBIO Highway),
1 × DMEM (Gibco), 10% FBS (Natocor), 50 µg/mL gentamicin
(Sigma-Aldrich), 1 × non-essential amino acids (STEMCELL),
200 ng/mL cycloheximide, 200 µg/mL spectinomycin (Sigma-
Aldrich) or 1 IU/mL penicillin (Sigma-Aldrich)] and incubated
at 37◦C and 5% CO2 for 8–14 days until plaques became visible.
Plaques were picked using a pipette tip and used to infect Vero
cell monolayers in 96 well plates. After 48 h of growth, infected
cells were lysed by hypotonic disruption for expansion.
Generation of Chlamydia Recombinants
Strains by Lateral Gene Transfer
Recombinant strains were generated as previously described
(Nguyen and Valdivia, 2012). Briefly, confluent Vero cells seeded
on a 6-well plate were coinfected with the rifampin resistant
mutant M275 and the spectinomycin resistant wild type strain
at an MOI of 3 (one set of 3 wells) and 6 (one set of 3 wells),
always with a 1:1 ratio mutant:wild type. At 44 hpi, bacteria
were harvested by osmotic lysis and resuspended in 400 µL SPG
1x per well. Then, confluent monolayers of Vero cells seeded
onto 6-well plates were infected with serial dilutions of the
recombinants (100 µL per well, spanning from undiluted up
to 10−5). At 2 hpi cells were overlayed with DMEM/agarose
[0.5% LE agarose (INBIO Highway), 1 × DMEM (Gibco), 10%
FBS (Natocor), 50 µg/mL gentamicin (Sigma-Aldrich), 1× non-
essential amino acids (STEMCELL), 200 ng/mL cycloheximide,
200 µg/mL spectinomycin (Sigma-Aldrich) and 200 ng/mL
rifampin (Sigma-Aldrich)] and incubated at 37◦C and 5% CO2
for 8–14 days until plaques became visible. Recombinant progeny
was selected from ∼50 plaques that formed in the presence of
200 ng/mL Rif and 200 µg/mL Spc. Plaque-purified recombinants
were further expanded in Vero cells and genotyped by TILLING
assay as described elsewhere (Till et al., 2006; Kari et al., 2011)
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in order to monitor the segregation of mutations in bioF, recC,
oppC and ptr genes that were present in the M275 mutant.
Except for one isolate which was isogenic to M275, all other
recombinants were wild type for ptr. Mutations present in rs9 and
rs17 were confirmed by Sanger sequencing (data not shown) with
the primers indicated in Supplementary Table S1.
Generation of ptr Null Strain
All cloning steps were performed in Escherichia coli DH5a. The
insertion site was chosen using the TargeTronR target selection
algorithm (Sigma) considering high score and closest proximity
to the 5′ ATG start codon. Primers used for re-targeting vector
pDFTT3aadA as directed by the TargeTronR manual are listed
in Supplementary Table S1. The PCR product was cloned into
the BsrGI/HindIII site in pDFTT3aadA plasmid (Lowden et al.,
2015). The resulting plasmid pME1 was verified by restriction
analysis and Sanger sequencing (data not shown). This plasmid
was later used to transform C. trachomatis LGV-L2 as described
above. Disruption of the ptr gene was confirmed by PCR and
sequencing of the PCR product obtained with primers Ptr2F and
Ptr2R (Supplementary Figures S4, S5).
Complementation of L2 ptr::GII
To complement the LGV-L2 ptr knock-out strain (L2 ptr::GII),
ctl0175 was amplified by PCR from C. trachomatis LGV-L2
purified genomic DNA (DNeasy kit, Qiagen) using F-rpoBPtr
and R-PtrFLAG primers (Supplementary Table S1). The PCR
product was cloned into SacII/KpnI-digested pBOMB4R-MCI
(Bauler and Hackstadt, 2014) and transformed into E. coli DH5a.
The resulting plasmid pBOMB-ptrF was verified by restriction
analysis and Sanger sequencing (data not shown) and used to
transform C. trachomatis LGV-L2 and L2 ptr::GII strains as
described above.
One-Step Growth Curve
HeLa cell monolayers were infected with the specified
C. trachomatis strains at an MOI of 0.6 until the indicated
time points (6, 20, 24, 30, 42 hpi), at which bacteria were
harvested by osmotic lysis. Serial dilutions of these lysates were
used to infect HeLa cells. Infected cells were fixed with methanol
at 30 hpi, labeled with anti-Slc1 and with a secondary Alexa Fluor
488-conjugated anti-rabbit IgG. Inclusions were imaged at 20x
magnification with a Leica DMI8 epifluorescence microscope
and counted to determine output IFUs. Output IFUs were
normalized by input IFUs (initial inoculum).
Determination of Inclusion Size
To measure inclusion size in untreated (24 and 30 hpi), IFNγ-
treatment (IFN: cells were pre-treated for 24 h with 15 ng/mL
of IFNγ, then infected for 24 h in presence of IFNγ), or IFNγ-
recovery (IFN-Rec: at 48 hpi, 24 h after removal of IFNγ and
addition of tryptophan) conditions, bacteria were labeled with
anti-Slc1 antibodies (Saka et al., 2011), and the area of the
inclusions was measured and expressed in arbitrary units using
an ImageJ macro.
Genome Copy Number Quantification
For determination of genome copy number, DNA was isolated
from infected HeLa cells at the indicated conditions (with
IFNγ at 2, 24, 48, and 72 hpi; post IFNγ after Trp addition
at 48 and 72 hpi) using the DNeasy kit (Qiagen) and
following manufacturer’s instructions. Reactions were prepared
with PowerUp SYBR Green Master Mix and quantitative PCR
was performed on a 7500 Real-Time PCR device (Applied
Biosystems). ompA was PCR amplified from C. trachomatis
LGV-L2 genomic DNA using FompA_BamHI and RompA_SalI
(Supplementary Table S1). PCR product was cloned into the
BamHI/SalI site of pET24d and transformed into E. coli DH10B.
pET24d_OmpA purified plasmid was quantified with Qubit
(Thermo Fisher Scientific) and used to generate a standard
curve. ompA copies were quantified using primers MOMP_F and
MOMP_R (Supplementary Table S1). Cycling conditions were:
10 min at 95◦C, followed by 40 cycles of 95◦C for 15 s and
60◦C for 1 min.
Transmission Electron Microscopy
To evaluate the ultrastructural features of HeLa cells infected with
the specified strains, the infected cell monolayers were fixed at the
indicated hpi with 2.5% glutaraldehyde/0.1M sodium cacodylate
and scraped from the wells. Fixed cells were centrifuged 5 min
at 1500 rpm and the pellets post-fixed, de-hydrated, embedded,
cut, and examined as described previously (De Paul et al.,
2009). RifR and M275 samples were processed in Duke Electron
Microscopy Facility; L2 wt, L2 ptr::GII and L2 ptr::GII PTR-F
samples were processed by the Electron Microscopy Center of
Facultad de Ciencias Médicas, Universidad Nacional de Córdoba.
To enumerate the numbers of EBs and RBs, at least 10 inclusions
were analyzed per condition. Images were processed with Adobe
Photoshop CS6 (Adobe Systems Inc.,).
Immunodetection Assays
Primary rabbit antibodies used were anti-HA epitope tag
(Life Technologies, 715500), anti-Slc1 (CT043) (Saka et al.,
2011) and anti-IncA (Cocchiaro et al., 2008). Primary mouse
antibodies were: anti-MOMP (Abcam, ab20881) and anti-FLAG
M2 (Sigma-Aldrich, F3165). Mouse polyclonal Abs were raised
against C. trachomatis LGV-L2 Ptr peptide (GenScript) as
described below. Secondary antibodies were Alexa Fluor 488
or 594 anti-mouse or anti-rabbit (Jackson Immuno Research).
DNA was stained with Hoechst 33258 (Life Technologies).
Immunofluorescence images were acquired on a Leica DMI8
epifluorescence microscope and on an Olympus FV1000 confocal
microscope. Images were processed with ImageJ 1.51n and/or
Adobe Photoshop CS6. For co-localization analysis of Ptr and
Ptr-FLAG (Figure 5), BAR plugin for ImageJ was used (data
repository: DOI 10.5281/zenodo.28838). For deconvolution of
z-stack images (image used for Figure 5E and Supplementary
File S1), the Huygens Professional Software (Scientific Volume
Imaging, Netherlands) was used, using the classical maximum
likelihood estimation algorithm, a theoretical PSF, a signal-
to-noise ratio of 10, a maximum of 40 iterations and
an automatic background search. The co-localization movie
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(Supplementary File S1) of Ptr (green) and CT143 (red) was
generated with Huygens Surface Renderer software (Scientific
Volume Imaging B.V.) with the following transparency settings:
green channel 100%, red channel, 0%. For western blots, protein
extracts were generated by lysing cells or tissues as recommended
by Biorad protocols and heated at 90◦C for 5–10 min. Equal
amounts of protein were resolved by SDS/PAGE, transferred
onto 0.45 µm nitrocellulose membranes (Biorad), and incubated
overnight with the corresponding primary antibodies followed by
fluorescently labeled secondary antibodies (LI-COR Biosciences).
Bands were visualized with Odyssey CLx imaging system (LI-
COR Biosciences). To perform fractionation of bacteria (pellet)
and HeLa lysates (supernatant), cells were infected with L2 PTR-F
or L2 ptr::GII PTR-F strains and gently lysed with 400 µL of water
(15 min, 37◦C) at 30 hpi. Lysates were centrifuged (15,000 rpm,
4◦C, 15 min) to separate the bacterial pellet from the supernatant.
To lyse bacteria, the pellet was resuspended in lysis buffer [20 mM
Tris.HCl pH 8, 5 mM EDTA, 50 mM NaCl, 1% Triton X100,
1 mM PMSF, protease inhibitor cocktail (Roche), 1% SDS, 15 mM
DTT,14.3 mM 2-mercapto ethanol]. Both bacterial and host cell
lysates were mixed with Laemmli buffer (2x final), sonicated (20%
amplitude, 1 min.) on ice, incubated 10 min at 65◦C and boiled
for 10 min. Protein lysates were resolved by SDS-PAGE and
immuno-blotted for FLAG (Ptr-FLAG) and MOMP.
Polyclonal Antibody Production
Purebred male C57BL/6 mice (aged 10 weeks) housed at
the vivarium of the Instituto Mercedes and Martín Ferreyra
were used to generate mouse polyclonal antiserum against
C. trachomatis LGV-L2 Ptr peptide. Mice were maintained in the
SPF animal facilities with environmental enrichment that meet
the conditions of the Guide to the Care and Use of Experimental
Animals (CICUAL N◦ 001-2017). Immune Epitope Database
Analysis Resource1 was used for peptide selection. Regions
with predicted beta-turn conformation, high antigenicity, surface
accessibility, and hydrophilicity were positively considered.
The selected peptide (SSPYAAPSYYPQRKP) was synthesized
with Keyhole Limpet Hemocyanin (KLH) conjugation on
the N-terminal end (GenScript). Cysteine was added at the
N-terminus for KLH conjugation. The chosen peptide is located
in CTL0175 protein sequence between amino acids 746 and
760. This region is upstream the predicted stop codon in
M275 (W801∗). Two male C57BL/6 mice were intraperitoneally
injected with 200 µg of antigen emulsified with Sigma Adjuvant
System (SAS) (Sigma-Aldrich, St. Louis, MO, United States)
(1:1) in a final volume of 200 µl on days 1, 21, and 45.
Polyclonal antisera were obtained after the second and the
third immunization and the production of anti-Ptr antibodies
were analyzed by immunofluorescence (IF) and immunoblotting.
The anti-Ptr antibody obtained was useful for IF but not for
immunoblot assays. In order to determine antibody specificity
in IF, anti-Ptr antibodies were incubated with the synthetic
Ptr peptide (0.5 mg) overnight at 4◦C on a rocker, and then




Statistical analysis was performed using GraphPad Prism 5.0
(∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ns, not significant, P> 0.5).
Tests performed are detailed in the corresponding figure legends.
RESULTS
A Genetic Screen Identifies
C. trachomatis Mutants Impaired for
Recovery From IFNγ- and
Penicillin-Induced Stress
To identifyC. trachomatis genes relevant for recovery from IFNγ-
and penicillin-induced stress, we screened a previously described
collection of ∼ 900 chemically mutagenized C. trachomatis
LGV-L2 strains (Kokes et al., 2015). We first set up stress
and recovery conditions for C. trachomatis LGV-L2 in HeLa
cells using IFNγ or penicillin as stressors. For IFNγ-induced
stress, HeLa cells were pre-treated for 24 h with 15 ng/mL of
IFNγ, then infected for 24 h in presence of the stressor and
allowed to recover for 24 h in IFNγ-free media supplemented
with tryptophan. For penicillin-induced stress, HeLa cells were
infected for 24 h in presence of 1 IU/mL of penicillin and
then allowed to recover for 24 h in penicillin-free media. As
previously reported (Tamura and Manire, 1968; Beatty et al.,
1993), we observed that in continuous presence of the stressors,
the generation of infectious progeny was drastically reduced
compared to the untreated control. At 24 h upon removal
of the stressors, the production of infectious progeny peaked
(up to 4 and 3 orders of magnitude in the case of IFNγ
and penicillin, respectively) compared to the stressed condition.
However, progeny generation post-recovery still was significantly
lower (1 and 2 orders of magnitude in the case of IFNγ
and penicillin, respectively) compared to the untreated control
(Supplementary Figure S1A). In the presence of penicillin,
inclusions clearly showed Chlamydia forms compatible with
the typical enlarged, aRBs (Supplementary Figure S1B). In the
presence of IFNγ, inclusions were smaller but the observation
of typical aRBs was not as evident as compared to penicillin
treatment (Supplementary Figures S1B–D). This is consistent
with the observation that C. trachomatis LGV-L2 is less sensitive
to IFNγ compared to other serovars (Morrison, 2000) and
may explain why IFNγ-induced aRB formation were more
difficult to observe (reviewed in Bavoil, 2014). In our culture
conditions, addition of 15 ng/ml of IFNγ clearly prevented
infectious progeny generation but aRB formation was not readily
observed. This may indicate that IFNγ-treatment managed to
cause nutritional stress due to reduced tryptophan availability,
but did not induce a “fully persistent” state. Because higher
concentrations of IFNγ were toxic to cell monolayers (data
not shown), we did not increase the levels of this cytokine
in our screen. After 24 h of recovery from IFNγ-induced
stress, inclusions were morphologically indistinguishable from
the untreated control. In contrast, removal of penicillin did not
completely revert the abnormal RB morphology (Supplementary
Figure S1B) as has been previously reported (Skilton et al., 2009).
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FIGURE 1 | A genetic screen identifies a C. trachomatis mutant impaired for recovery from IFNγ-induced stress. (A) Schematic representation of the phenotypic
screen used to identify C. trachomatis mutants impaired for recovery from IFNγ- or penicillin (PEN)-induced stress. Four identical arrays of the mutant strains were
prepared in 96 well plates; one array was used to determine the input of infectious forming units (Input IFU) while the other three were used to determine output IFUs
(IFU) at the indicated hours post-infection (hpi) in either the untreated (UT, upper panel), IFNγ-recovery (IFN-Rec, middle panel) or PEN-recovery condition (PEN-Rec,
lower panel). For IFNγ-induced stress, cells were pre-treated for 24 h with 15 ng/ml of IFNγ prior to infection. At 24 hpi the stressor was removed and tryptophan
(100 mg/L) was added to the culture medium to evaluate the recovery of IFUs at 48 hpi (IFN-Rec). For PEN-induced stress, penicillin (1 IU/mL) was added at the time
of infection and removed at 24 hpi to evaluate the recovery of IFUs at 48 hpi (PEN-Rec). As control, wild type C. trachomatis LGV-L2 was included in the arrays.
(B) C. trachomatis mutants with impaired production of infectious progeny normalized per input (IFU/Input) upon recovery from IFNγ- or PEN-induced stress (gray
dots, red star, n = 8) compared to wild type C. trachomatis LGV-L2 (L2 wt, black dots). The mutant strain M275 (red star) reproducibly showing impaired generation
of IFUs in the recovery from IFNγ- but not PEN-induced stress was chosen for further characterization. (C) Fluorescence microscopy micrographs of HeLa cells
infected with LGV-L2 (L2 wt, upper panels) or M275 (lower panels) in either untreated (UT, 30 hpi), IFNγ-treated (IFN: cells pre-treated for 24 h with 15 ng/mL of
IFNγ, then infected for 24 h in presence of IFNγ), or IFNγ-recovery (IFN-Rec: at 48 hpi, 24 h after removal of IFNγ and addition of tryptophan). Insets highlight
representative inclusions under UT and IFN conditions. C. trachomatis inclusions were labeled with anti-Slc1 (red) and DNA was stained with Hoechst (blue). Scale
bar represents 10 µm. (D) Comparison of inclusion sizes (expressed in arbitrary units, a. u.) between LGV-L2 (L2 wt) and M275 in UT, IFN or IFN-Rec conditions.
Asterisks indicate statistically significant differences (?P < 0.001) between M275 and L2 wt as determined by two-way ANOVA and Bonferroni post-test (bar, mean;
shaded area, SEM, n = 3).
We next reasoned that C. trachomatis mutants exhibiting
reduced levels of infectious progeny upon removal of the
stressors, are defective either in their ability to survive during
stress or to resume growth/progeny generation. To identify
such mutants, we infected HeLa cells with individual chemically
derived mutant strains in the presence of IFNγ or penicillin,
then removed the stressors at 24 hpi and allowed the bacteria to
recover for an additional 24 h (Figure 1A). We then measured
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the generation of infectious progeny for each mutant by counting
inclusion forming units (IFUs) in untreated condition at 30 hpi
(UT), or at 24 h of recovery from IFNγ- or penicillin-induced
stress (IFN-Rec and PEN-Rec conditions, respectively). To
account for variations in infectivity among mutant strains, output
IFUs were normalized to input IFUs (IFU/Input). A defective
mutant was defined as that producing ≤10% and/or ≤20% of
IFU/Input upon recovery from IFNγ- and penicillin-induced
stress, respectively, compared to the LGV-L2 control strain.
We identified 8 mutants displaying reduced IFU generation
upon recovery from IFNγ-induced stress, 3 of which were
also defective for reactivation upon penicillin-induced stress
(Figure 1B). We focused our analysis on mutant M275, which
reproducibly showed impaired recovery from IFNγ- but not
penicillin-induced stress. To determine the effect of IFNγ
treatment on inclusion development, we measured inclusion size
for wild type and M275 strains. In the absence of stressors,
wild type and M275 strains developed inclusions that were
similar in size. Interestingly, after removal of IFNγ, M275
showed significantly smaller inclusions compared to the parental
strain (Figures 1C,D).
M275 Is Defective for Recovery From
IFNγ- but Not Penicillin-Induced Stress
To determine if the stress-recovery defect of M275 was specific
for IFNγ-induced stress, we analyzed the generation of IFUs
upon recovery from IFNγ- and penicillin-induced stress at three
different time-points: 48, 56, and 72 hpi, corresponding to 24,
32, and 48 h of recovery, respectively. In the UT and PEN-Rec
conditions M275 generated similar IFUs/Input compared to the
RifR wt parental strain (Supplementary Figures S2A, S2C). In
contrast, in the IFN-Rec condition M275 showed a significant
reduction in IFU generation in all three time-points analyzed
(Supplementary Figure S2B). These results confirm that M275
exhibits a defect specifically in the recovery from IFNγ- but not
penicillin-induced stress, indicating that C. trachomatis recover
from these two stresses via different mechanisms. We next
analyzed HeLa cells infected with the control strain or M275 by
electron microscopy to evaluate the ultrastructural features of
developmental forms in the UT and IFN-Rec conditions. In the
UT condition, M275 displayed no apparent anomalies compared
to the control strain (Supplementary Figure S2D). However,
M275 showed a significant reduction in both the absolute number
of EBs per inclusion as well as in EB/RB ratio upon recovery
from IFNγ-induced stress (Supplementary Figures S2D,E). To
determine if the reduction in IFUs and the EB/RB ratio observed
in M275 was associated to a defect in genome replication during
recovery from IFNγ-induced stress, we used real-time PCR
and assessed the rate of genome accumulation. We found that
compared to the parental control strain, M275 exhibited reduced
genome accumulation during recovery from IFNγ-induced stress
(Supplementary Figure S2F).
Recombinant Analysis Indicates That
Neither Mutations in recC or oppC Are
Linked to the Phenotype Observed in
M275
Whole-genome sequencing of M275 revealed 6 single nucleotide
variants (SNVs) compared to the parental RifR wt strain
(Table 1). Two of them (G126A and C204T) lead to synonymous
mutations. SNVs in recC (C1003T), oppC (G541A) and bioF
(G566A) are predicted to cause single amino acid substitutions
(Table 1). One SNV located in ptr (C2403T) is predicted to
cause a premature stop codon (W801∗) and thus it is the
TABLE 1 | Single nucleotide variants present in the genome of M275.
Genome position1 Base pair substitution2 Gene Locus ID3 Amino acid substitution
123,163 C→ A
127,338 T657A CTL0103
435,453 G743A nusA CTL0352 A248V
448,523 G110A CTL0364 A37V
616,827 C315T CTL0518
637,039 C610T clpC CTL0538 R204C
638,353 T1924C clpC CTL0538 F642L
675,519 G1411A rpoB CTL0567 H471Y
693,265 G473A pykF CTL0586 S158N
798,820 G470A pmpC CTL0671 G157E
929,717 C→ A
12,648 C1003T recC CTL0008 V335I
191,773 G566A bioF CTL0146 G189E
222,833 C2403T ptr CTL0175 W801∗
324,164 G126A gatC CTL0257
544,104 G541A oppC CTL0452 A181T
925,215 C204T CTL0802
Mutations shaded in gray are mutations present in the parental RifR LGV-L2 434/Bu strain (Nguyen and Valdivia, 2012). 1Genome position of base pair substitution
induced by EMS mutagenesis (Kokes et al., 2015). 2Base pair substitution in coding domain sequence. 3C. trachomatis LGV-L2 434/Bu reference genome locus ID. The
asterisk (∗) indicates the stop codon. Red color highlights the mutation causing a premature stop codon in ptr.
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FIGURE 2 | Insertional inactivation of ptr leads to impaired recovery of C. trachomatis from IFNγ-induced stress. (A) LGV-L2 ptr knock out (L2 ptr::GII), LGV-L2
transformed with the plasmid vector pBOMB-ptrF expressing FLAG-tagged Ptr (L2 PTR-F) and LGV-L2 ptr knock-out transformed with pBOMB-ptrF (L2 ptr::GII
PTR-F), display similar levels of infectious progeny generation compared to C. trachomatis LGV-L2 wild type (L2 wt) strain in the untreated (UT) condition. The
number of infectious bacteria was quantified at 30 hpi and normalized to the input (mean ± SEM, n = 3, Student’s t-test). (B) The ptr knock-out strain L2 ptr::GII
(Continued)
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FIGURE 2 | Continued
exhibits decreased generation of infectious progeny upon recovery from IFNγ-induced stress (IFN-Rec), while this phenotype is rescued by expression of Ptr from a
plasmid vector in the L2 ptr::GII PTR-F strain. HeLa cells were pre-treated with IFNγ (15 ng/mL) for 24 h and infected with the indicated strains. At 24 hpi, IFNγ was
removed, cells were supplemented with tryptophan (100 mg/L) and incubated for various times post-infection to assess recovery. Infectious progeny post-recovery
was quantified at 48, 56, and 72 hpi and normalized to the input (mean ± SEM). Statistical analysis was performed by Student’s t-test (n = 3; ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001). (C) L2 ptr::GII produces infectious progeny at similar levels than L2 wt upon recovery from penicillin-induced stress (PEN-Rec). HeLa cells were
infected with the indicated strains and supplemented with penicillin (1 IU/mL) at the time of infection. At 24 hpi penicillin was removed, cells were replenished with
complete medium and incubated up to 48, 56, or 72 hpi for recovery. Since pBOMB-ptrF carries ampicillin resistance, L2 PTR-F and L2 ptr::GII PTR-F are not
affected by penicillin. In all cases, infectious progeny was normalized by input (mean ± SEM, n = 3). Statistical analysis was performed by Student’s t-test
[non-significant (ns), P > 0.05]. (D) Representative TEM images of the untreated (UT, 30 hpi) and of IFN-Rec (48 hpi) conditions for HeLa cells infected the L2 wt, L2
ptr::GII and L2 ptr::GII PTR-F strains. Insets highlight C. trachomatis particles displaying typical ultrastructural features of EBs and RBs. Scale bars represent 2 µm.
(E) Quantification of EBs/inclusion and EBs/RBs visualized by TEM during IFN-Rec. Values represent the mean ± SEM of at least three replicates. Statistical
significance was calculated by Student’s t-test (∗∗P < 0.01 and ∗∗∗P < 0.001). (F) HeLa cells were treated with IFNγ for 24 h and infected with either L2 wt, L2
ptr::GII or L2 ptr::GII PTR-F strains. For the recovery condition (Rec), IFNγ was removed at 24 hpi and cells were replenished with full media supplemented with
tryptophan. For the non-recovery condition (NoRec) IFNγ was continuously present during infection. Genome copy number was assessed by real-time PCR during
IFNγ treatment and upon recovery at the indicated times post-infection using primers specific for ompA. Data points represent the mean of three replicates.
most likely to alter the function of the resulting protein. To
determine which mutations are linked to the stress-recovery
defect observed for M275, we generated recombinant strains
by performing co-infections between the rifampin resistant
M275 and a spectinomycin resistant LGV-L2 strain followed
by selection of double drug-resistant recombinants by plaque-
purification (Supplementary Figure S3A). A total of ∼50
recombinants were genotyped by TILLING assay (Till et al., 2006;
Kari et al., 2011) (data not shown). Two recombinant strains, rs9
and rs17, harbored a single SNV in oppC, and SNVs in oppC
and recC, respectively, leading to single amino acid substitutions
(Table 1). Both recombinants were tested in IFNγ-induced stress
and recovery assays and compared to M275 and RifR wt. In the
UT condition, generation of IFUs for both recombinants was
similar to RifR wt, as expected (Supplementary Figure S3B).
Unlike M275, which consistently showed a significant reduction
in IFU generation in all three time-points analyzed upon recovery
from IFNγ-induced stress, rs9 and rs17 produced higher levels
of IFUs, similar to those observed for RifR wt (Supplementary
Figure S3C). These results suggested that neither recC nor oppC
contributed to impaired recovery from IFNγ-induced stress.
Impaired Recovery From IFNγ-Induced
Stress Is Linked to the Loss of Ptr
Expression
We turned our attention to the remaining candidate mutations
present in M275: bioF and ptr. bioF is predicted to encode
a 7-keto-8-aminopelargonate (KAPA) synthase, which may
participate in the first step of synthesis of biotin by converting
pimeloyl-CoA to KAPA (Fisher et al., 2012). ptr corresponds
to locus CTL0175 in C. trachomatis LGV-L2 and encodes an
uncharacterized putative Zn2+-dependent metalloprotease with
peptidase domains of the M16 superfamily. Since the SNV
present in ptr leads to a premature stop codon, we focused on
this gene as the most likely candidate responsible for the impaired
recovery of M275 from IFNγ-induced stress. To evaluate Ptr
expression in M275, we generated a polyclonal antibody against
a synthetic peptide corresponding to amino acid positions
746–760 in Ptr protein sequence, which is located 5′ to the
predicted nonsense codon. By immunofluorescence microscopy
(Supplementary Figure S3D) Ptr labeling was detected in the
RifR wt strain, but not in M275. Furthermore, the specificity of
the anti-Ptr antibody was confirmed by incubation with an excess
of the immunizing Ptr peptide, which led to a marked reduction
of the anti-Ptr fluorescence signal (Supplementary Figure S3E).
We next inactivated ptr in C. trachomatis LGV-L2 with
a ptr-targeting group II intron (L2 ptr::GII strain) carrying
a spectinomycin resistance cassette (Lowden et al., 2015).
Disruption of the chromosomal copy of ptr in L2 ptr::GII was
confirmed by PCR reactions and sequencing (Supplementary
Figures S4, S5 and Supplementary Table S1). To complement
Ptr expression, we transformed L2 ptr::GII with the plasmid
pBOMB-ptrF, which expresses Ptr fused to a FLAG epitope (L2
ptr::GII PTR-F strain). As a control, we also transformed wild
type C. trachomatis LGV-L2 with pBOMB-ptrF (L2 PTR-F strain)
to determine if overexpression of Ptr from a plasmid elicits a
detrimental effect. In the absence of stressors, all the strains
generated similar levels of IFUs (Figure 2A) and exhibited similar
growth rate in a one-step growth curve analysis (Supplementary
Figure S6) compared to the wild type strain. This indicates
that ptr is dispensable for the development of a productive
cycle and that Ptr-FLAG overexpression is not detrimental to
C. trachomatis. L2 ptr::GII was impaired for recovery from
IFNγ- but not PEN-induced stress (Figures 2B,C), reproducing
the phenotype observed for M275 (Supplementary Figure S2).
Importantly, we observed that during the IFN-Rec condition, L2
ptr::GII transformed with the pBOMB-ptrF plasmid produced
significantly more IFUs than L2 ptr::GII and similar levels of IFUs
compared to L2 wt and L2-PTR-F control strains (Figure 2B),
indicating that ectopic expression of Ptr rescued the ability to
reactivate after IFNγ-induced stress in the ptr knockout strain.
A similar assessment of recovery from penicillin-induced stress
could not be made for strains transformed with pBOMB-ptrF,
because this plasmid confers ampicillin resistance and thus the
transformed strains were not affected by penicillin (Figure 2C).
An ultrastructural analysis by electron microscopy indicated
that in the UT condition, L2 ptr::GII displayed no apparent
alterations compared to L2 ptr::GII PTR-F and L2 wt
(Figure 2D). However, during recovery from IFNγ-induced
stress, L2 ptr::GII inclusions contained significantly less EBs
and a reduced EB/RB ratio (Figure 2E), reproducing the
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phenotype of the original M275 mutant (Supplementary
Figure S2E). Importantly, this decrease in total EB numbers
and EB/RB ratio was rescued in the complemented strain
(Figures 2D,E). Next, we determined if the reduction in
IFU generation and EB/RB ratio observed in L2 ptr::GII was
associated with defects in genome replication during recovery
from IFNγ-induced stress. We assessed the rate of genome
accumulation (Figure 2F) and found that in the presence
of IFNγ, all strains showed a marked reduction in genome
replication. Upon removal of IFNγ, L2 ptr::GII exhibited
reduced genome accumulation compared to L2 wt. Importantly,
the complemented strain L2 ptr::GII PTR-F restored the
rates of genome accumulation to levels seen for the L2 wt
control. Altogether, these findings provide genetic confirmation
that loss of Ptr is associated with impaired recovery from
IFNγ-induced stress.
FIGURE 3 | Insertional disruption of ptr results in lack of Ptr expression and strains transformed with pBOMB-ptrF express FLAG-tagged Ptr (A) Representative
confocal images of HeLa cells infected with the indicated strains at 30 hpi. Ptr expression (green) was observed in wild type LGV-L2 (L2 wt, endogenous levels),
LGV-L2 expressing FLAG-tagged Ptr (L2 PTR-F) and LGV-L2 ptr knock-out expressing FLAG-tagged Ptr (L2 ptr::GII PTR-F) strains but not in LGV-L2 ptr knock-out
(L2 ptr::GII). Bacteria transformed with pBOMB-ptrF express mCherry (red). DNA was stained with Hoechst (blue). Scale bars, 10 µm. (B) Left panel: representative
confocal images of HeLa cells infected with the indicated strains at 30 hpi. FLAG-tagged Ptr (green) and mCherry (red) highlight inclusions only in cells infected with
L2 PTR-F and L2 ptr::GII PTR-F. DNA was stained with Hoechst (blue). Scale bars, 10 µm. Right panel: immunoblot with anti-FLAG M2 antibodies (FLAG) confirms
expression of the expected ∼109 kDa FLAG-tagged Ptr in total protein extracts obtained from HeLa cells infected with L2 PTR-F or L2 ptr::GII PTR-F. For loading
control, anti-MOMP antibodies were used (MOMP).
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We further confirmed expression of Ptr in complemented
strains by immunofluorescence microscopy with anti-Ptr
antibodies. Ptr labeling was detected in the inclusion of L2
wt, L2 PTR-F and L2 ptr::GII PTR-F strains, but not in L2
ptr::GII, as expected (Figure 3A). We also verified that strains
transformed with pBOMB-ptrF expressed FLAG-tagged Ptr
both by immunofluorescence and immunoblots with anti-FLAG
antibodies (Figure 3B).
Ptr Is Expressed at Mid-to-Late Stages
of C. trachomatis Developmental Cycle
and Localizes to the Lumen of Inclusions
We assessed the expression of Ptr by immunofluorescence at
different stages during the developmental cycle in HeLa cells
infected with C. trachomatis LGV-L2. Endogenous Ptr expression
FIGURE 4 | Ptr is expressed at mid to late stages of C. trachomatis
developmental cycle. (A) Representative micrographs of HeLa cells infected
with LGV-L2 at 18-24-30-48 hpi. (B) Representative images of HeLa cells
infected with LGV-L2 during IFNγ treatment (IFN: cells were pre-treated for
24 h with 15 ng/mL of IFNγ, then infected for 24 h in presence of IFNγ) and
upon recovery from IFNγ-induced stress (IFN-Rec: at 48 hpi, 24 h after
removal of IFNγ and addition of tryptophan). Anti-Ptr (green) shows Ptr
expression and anti-IncA (red) marks the boundaries of the inclusion
membrane. Confocal images are depicted. Scale bars, 10 µm.
was detected at 18, 24, and 30 hpi, and barely detected at 48 hpi,
suggesting that at late stages of the developmental cycle the
expression of this protein decreases (Figure 4A). In addition,
we determined that Ptr is expressed during IFNγ-induced stress
and recovery (Figure 4B). By immunofluorescence microscopy,
HeLa cells infected with L2 ptr::GII PTR-F displayed anti-FLAG
labeling localizing to bacteria and to the intraluminal space
within inclusions (Figure 5A). Immunostaining of Ptr with
anti-Ptr antibodies mirrored the localization pattern observed
with anti-FLAG, both at ectopically expressed and endogenous
levels (Figures 5B,C), emphasizing the specificity of the anti-
Ptr antibodies. Overall, our immunostaining suggests that Ptr is
present within inclusions and outside of the bacteria cells. Ptr
contains a putative signal peptide for Sec-dependent secretion,
indicating that this protein may be secreted into the inclusion
lumen. It has been previously reported that other chlamydial
proteases like HtrA, Tsp and CPAF are secreted and localize to
organism-free vesicles within the lumen of inclusions (Zhong,
2011). In addition, other Chlamydia proteins like Pls1 and Pls2
(Jorgensen and Valdivia, 2008) and the type III secretion system
substrates CT142, CT143, and CT144 (da Cunha et al., 2017)
have also been reported to localize outside of the bacterial
cells but within the inclusion lumen. To determine if Ptr
co-localized with any of the previously characterized secreted
intra-inclusion proteins, we transformed a plasmid expressing
CT143 fused to an HA epitope tag (pCT143-2HA, da Cunha
et al., 2017) into C. trachomatis LGV-L2 and assessed the
subcellular localization of CT143 and Ptr by immunofluorescence
microscopy. The localization of CT143 in C. trachomatis LGV-
L2 transformed with pCT143-2HA reproduced the intraluminal
localization pattern previously reported (da Cunha et al.,
2017). Interestingly, CT143-2HA and Ptr partially co-localized
with extra-bacterial particles within the inclusion (Figure 5E).
A surface render of the inclusion shown in Figure 5E further
supports the observation that Ptr can be found closely associated
to CT143 positive structures in the inclusion lumen (movie
Supplementary File S1).
To independently confirm secretion of Ptr, we carried out
fractionation of HeLa cells infected with C. trachomatis LGV-
L2 strains expressing Ptr-FLAG to separate bacterial cells (pellet)
from host cell lysate (supernatants). As observed in Figure 5F,
by immunoblot analysis the major Chlamydia outer membrane
protein MOMP was only detected in the bacterial pellets, while
Ptr-FLAG was detected both in the bacterial pellets and in the
supernatants. Overall, these results lead us to postulate that a
significant portion of Ptr is released from Chlamydia cells and
localize to extra-bacterial particles within the inclusion lumen.
DISCUSSION
We used a collection of chemically mutagenized C. trachomatis
strains (Kokes et al., 2015) to identify C. trachomatis genes
potentially involved in recovery from IFNγ- and/or penicillin-
induced stress. In this report, we characterized one mutant,
M275, which showed impaired recovery from IFNγ- but not
penicillin-induced stress. This mutant harbored 6 SNVs, one
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FIGURE 5 | Ptr localizes to extra-bacterial particles within the lumen of the inclusion. (A) Upper panel: representative image of HeLa cells infected with LGV-L2 ptr
knock-out expressing FLAG-tagged Ptr (L2 ptr::GII PTR-F) at 30 hpi. Freehand lines regions of interest crossing the inclusion (ROIs) 1 and 2 are indicated. Lower
panels: multichannel plot profiles corresponding to the indicated ROIs (1, 2) depict the fluorescence intensities (a. u., arbitrary units) of Ptr-FLAG (green) and
mCherry-expressing bacteria (red). (B) Upper panel: representative image of HeLa cells infected with LGV-L2 expressing FLAG-tagged Ptr (L2 PTR-F) at 30 hpi.
(Continued)
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FIGURE 5 | Continued
ROIs 1 and 2 are indicated. Lower panels: multichannel plot profiles corresponding to the indicated ROIs (1, 2) depict the fluorescence intensities of FLAG-tagged
and endogenous Ptr (green) and mCherry expressing bacteria (red). (C) Upper panel: representative image of HeLa cells infected with LGV-L2 expressing mCherry at
30 hpi. ROI 1 is indicated. Lower panel: multichannel plot profile corresponding to the indicated ROI (1) depict the fluorescence intensities of endogenous Ptr (green)
and mCherry (red). Ptr was labeled with either anti-FLAG M2 (A) or anti-Ptr (B,C) antibodies. Bacteria constitutively express mCherry due to pBOMB-ptrF (A,B) or to
p2TK2-SW2-mCherry (C) plasmids. (A–C) Note that FLAG-tagged Ptr and endogenous Ptr localize to bacteria (blue arrows) and to the intraluminal space within the
inclusion (red arrows). (D) Upper panel: HeLa cells were infected with LGV-L2 expressing hemagglutinin (HA) epitope-tagged CT143, fixed at 30 hpi and labeled with
anti-HA and anti-MOMP. CT143-HA localizes to extra-bacterial particles within the inclusion lumen (da Cunha et al., 2017). ROI 1 is indicated. Lower panel:
multichannel plot profile corresponding to the indicated ROI (1) depict the fluorescence intensities of CT143-HA (green) and MOMP (red). Red arrows indicate CT143
localization outside the bacteria, blue arrow indicates CT143-HA labeling surrounded by anti-MOMP signal. DNA was stained with Hoechst. Confocal images are
depicted. (E) Left panel: co-localization of Ptr and CT143-HA in HeLa cells at 30 hpi. A confocal single z-section is depicted. Inset highlights co-localizing structures
(arrowheads). Right panel: multichannel plot profile corresponding to the indicated ROI in left panel depict the intensities of red (CT143-HA) and green (Ptr)
fluorescence. Blue arrow indicates co-localizing structures. A surface render of this inclusion performed with Huygens Professional Software is included in the movie
Supplementary File S1. (F) Distribution of Ptr as assessed by fractionation of HeLa cells infected with L2 PTR-F or L2 ptr::GII PTR-F at 30 hpi. Bacterial pellets
(PELLET) and supernatants (SN) were immunoblotted with anti-FLAG (Ptr-FLAG) and anti-MOMP (MOMP). Scale bars represent 10 µm (A–D) and 5 µm (E).
of them leading to a nonsense mutation in ptr gene. We
disrupted ptr in C. trachomatis LGV-L2 with a type II intron
(TargeTronR, Lowden et al., 2015) and generated a ptr null
strain (L2 ptr::GII) that reproduced the defect observed for
M275. Moreover, complementation of Ptr expression from a
plasmid restored the generation of infectious progeny upon
removal of IFNγ, confirming that ptr is required for recovery
from IFNγ-induced stress in C. trachomatis. This gene encodes
an uncharacterized secreted protease, which shares 23% identity
with the zinc-dependent protease III of E. coli K-12 (Pitrilysin, a
periplasmic enzyme that degrades small peptides). Ptr belongs to
the M16 peptidase family and includes a conserved motif between
amino acids 105–109 (H-X-X-E-H) in the N-terminal section
involved in enzymatic activity in Pitrilysin. An InterPro database
analysis of Ptr shows that the domain architecture of this protein
is shared by other peptidases of related and distant species. Ptr is
highly conserved across C. trachomatis serovars (>99% identity),
while identity level with Ptr orthologs varies considerably across
Chlamydia species (C. muridarum 82%, C. pneumoniae 47%, and
C. psittaci 46%).
A previous screen for C. trachomatis mutants impaired
for recovery upon removal of IFNγ used a GFP-expressing
LGV-L2 library as a primary read-out for the number of
inclusions formed in untreated compared to IFNγ recovery
conditions (Muramatsu et al., 2016). In this screen, IFNγ-
induced stress was achieved by pre-treating HeLa cells for
24 h with 10 ng/mL of IFNγ followed by infection for 24 h
in presence of the stressor, while recovery was assessed 24 h
after cells were washed and replenished with tryptophan-free
media supplemented with indole. Our screen instead used a
rifampin resistant LGV-L2 library of mutants and the read-out
was based on quantifying infectious progeny generation upon
recovery from the stressing condition. Another difference is that
we used 15 ng/mL of IFNγ for stress induction and assessed
recovery 24 h after cells were washed and replenished with media
supplemented with an excess of tryptophan. Remarkably, in this
independent screen Muramatsu et al. (2016) identified a defective
mutant, Sip5, with amino acid substitutions in Ptr/CTL0175
(P831S) and in CTL0641 (H37Y). However, this mutant was
not characterized further, so it remains unknown if the amino
acid substitution in Ptr was involved in the defect observed
for this strain.
Our results indicate that abrogation of Ptr expression causes
reduced recovery from IFNγ-induced stress due to impaired
RB to EB differentiation and reduced genome accumulation
(Supplementary Figures S2D–F and Figures 2D–F). Muramatsu
et al. (2016) also found mutants displaying altered rates of
genome accumulation and EB generation upon removal of IFNγ.
For instance, Sip6 (CTL0694P105L) presented uncoupled genome
replication and EB production whereas Sip2 (CTL0225G77E)
displayed decreased and delayed genome accumulation. These
findings suggest that altered genome accumulation and RB to
EB transition may be a cause of impaired recovery from IFNγ-
induced stress.
The expression of ptr mRNAs in C. trachomatis LGV-
L2 is relatively constant between 9 and 18 hpi in untreated
condition and no significant changes were observed in iron-
depleted conditions (Brinkworth et al., 2018). A transcriptional
study focused on IFNγ-induced persistence and reactivation in
C. trachomatis serovar D reported that ptr transcript levels were
reduced ∼ 2 fold during IFNγ treatment and removal (Belland
et al., 2003). Proteomics studies reported that Ptr is expressed
in all C. trachomatis developmental forms (Saka et al., 2011;
Ostergaard et al., 2016; Skipp et al., 2016). Saka et al. (2011)
and Skipp et al. (2016) proteomic studies found that Ptr is
expressed at higher levels in RBs compared to EBs, and scores
among the top 30 most abundant proteins in C. trachomatis
LGV-L2 RBs. A proteomic study by Ostergaard et al. (2016)
was carried out in C. trachomatis serovar D and reported
that Ptr levels did not change significantly in EBs, RBs or
aRBs. Interestingly, this study found that under IFNγ-induced
stress, the C. trachomatis serovar D proteome accumulates lower
levels of tryptophan-rich proteins. Given that C. trachomatis
Ptr has a relatively low tryptophan content compared to its
E. coli homolog, it has been suggested that C. trachomatis Ptr
has evolved to be expressed under IFNγ-induced tryptophan
deprivation (Lo et al., 2012). In our study, we were not able
to reliably measure Ptr expression levels by western-blot, since
the antibody we generated only worked for immunofluorescence.
However, our immunofluorescence observation that Ptr levels
seemed higher at 24 hpi compared to 48 hpi is in agreement
with previous proteomic data showing that Ptr is enriched in RBs
compared to EBs in C. trachomatis LGV-L2 (Saka et al., 2011;
Skipp et al., 2016).
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Our immunolocalization and cell fractionation studies
indicate that Ptr is released into the luminal space within
the inclusion, where it can be found outside of bacteria cells
(Figure 5). Interestingly, a subset of Ptr was found closely
associated to the type III-secreted protein CT143, which has
also been shown to localize inside the inclusion but outside
of the Chlamydia organisms (da Cunha et al., 2017). This
association, however, does not necessarily indicate that these two
proteins interact and if there is a functional implication for this
association, it remains to be determined.
CONCLUSION
Our work provides evidence that Ptr, a poorly characterized
protease, is secreted into the inclusion lumen and participates
in C. trachomatis exit from IFNγ- but not penicillin-induced
stress in vitro. The precise molecular mechanism by which Ptr
mediates these effects remains to be determined. Since in human
cells IFNγ-induced stress in C. trachomatis is mediated primarily
by deprivation of an amino acid (tryptophan), it is tempting to
speculate that the Ptr protease may be useful as an amino acids
provider during recovery. This could explain why Ptr loss is
associated to impaired recovery from IFNγ- but not penicillin-
induced stress. Further studies with strains harboring mutations
in the putative protease active site might be useful for uncovering
the potential role of Ptr peptidase activity during IFNγ-induced
stress and recovery.
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